Similar articles for PMID: 8639930

Year	Number of Results
1983	1
1984	2
1987	1
1990	2
1991	4
1992	6
1993	1
1994	1
1995	5
1996	3
1997	2
1998	4
2000	2
2001	2
2002	2
2003	1
2004	1
2005	2
2006	6
2007	4
2008	10
2009	15
2010	4
2011	12
2014	1
2015	3
2016	3
2017	2
2018	3
2019	2
2020	2
2021	4
2022	4
2023	4
2024	0

1

Desmopressin-induced thrombocytopenia in von Willebrand disease patients with the Arg611His mutation in the A1 domain of von Willebrand factor.

Castaman G, Rodeghiero F, Eikenboom J. Castaman G, et al. Blood. 1996 Apr 1;87(7):3061. Blood. 1996. PMID: 8639930 Free article. No abstract available.

2

A novel candidate mutation (Arg611-->His) in type I 'platelet discordant' von Willebrand's disease with desmopressin-induced thrombocytopenia.

Castaman G, Eikenboom JC, Rodeghiero F, Briët E, Reitsma PH. Castaman G, et al. Br J Haematol. 1995 Mar;89(3):656-8. doi: 10.1111/j.1365-2141.1995.tb08383.x. Br J Haematol. 1995. PMID: 7734373

3

von Willebrand's variant (type II Buffalo). Thrombocytopenia after desmopressin but absence of in vitro hypersensitivity to ristocetin.

Sweeney JD, Hoernig LA, Behrens AN, Novak E, Swank RT. Sweeney JD, et al. Am J Clin Pathol. 1990 Apr;93(4):522-5. doi: 10.1093/ajcp/93.4.522. Am J Clin Pathol. 1990. PMID: 2321583

4

Molecular basis of von Willebrand disease and its clinical implications.

[No authors listed] [No authors listed] Haematologica. 2004 Sep;89(9):1036. Haematologica. 2004. PMID: 15377463 No abstract available.

5

Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.

Castaman G, Federici AB, Bernardi M, Moroni B, Bertoncello K, Rodeghiero F. Castaman G, et al. J Thromb Haemost. 2006 Feb;4(2):357-60. doi: 10.1111/j.1538-7836.2006.01706.x. J Thromb Haemost. 2006. PMID: 16420565 Free article. Clinical Trial.

6

A personalized approach to the management of VWD.

Phua CW, Berntorp E. Phua CW, et al. Transfus Apher Sci. 2019 Oct;58(5):590-595. doi: 10.1016/j.transci.2019.08.009. Epub 2019 Aug 7. Transfus Apher Sci. 2019. PMID: 31466808 Review.

7

How I treat patients with von Willebrand disease.

Mannucci PM. Mannucci PM. Blood. 2001 Apr 1;97(7):1915-9. doi: 10.1182/blood.v97.7.1915. Blood. 2001. PMID: 11264151 Free article. Review.

8

Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.

Castaman G, Eikenboom JC, Contri A, Rodeghiero F. Castaman G, et al. Thromb Haemost. 2000 Aug;84(2):351-2. Thromb Haemost. 2000. PMID: 10959713 No abstract available.

9

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.

Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ. Gadisseur A, et al. Acta Haematol. 2009;121(2-3):145-53. doi: 10.1159/000214855. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506361 Review.

10

Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand disease.

Castaman G, Rodeghiero F, Lattuada A, Mannucci PM. Castaman G, et al. Am J Hematol. 1993 May;43(1):5-9. doi: 10.1002/ajh.2830430103. Am J Hematol. 1993. PMID: 8317462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year